Hepatitis B News
Most Popular Hepatitis B Story
Gilead HIV med OK'd for hepatitis
Gilead Sciences is expanding its expertise further beyond its long-held specialty in HIV treatment. Its AIDS drug Viread has now been FDA-approved as a treatment for chronic hepatitis B, joining... Read more...
Latest Headlines
- August 12, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
